Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03738410 · ClinicalTrials.gov registry record · NA
An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS
A NA study of HIV/AIDS, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT03738410: Recruiting NA study of HIV/AIDS, sponsored by University of Miami.
NCT03738410 is a NA study of HIV/AIDS that is actively recruiting participants, run by University of Miami. The registered enrollment target is 80 participants, below the 33,179-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03738410, a NA study of HIV/AIDS, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is: 1. To develop a new mobile health (mHealth) system that will send text messages to remind both pregnant and non-pregnant women with HIV to adhere to their treatment plan (like keeping appointments, fillings prescriptions, and taking their medication) and address individual barriers to HIV care (like stigma, medical mistrust and resilience). 2. The intervention will also include patient navigation and motivational interviewing 2\) Investigators also want to see if the mHealth system is feasible, easily accepted and if it will impact patient health in a positive way.
Primary Outcome
The proportion of participants enrolled and proportion of participants declined enrollment or screen failed out of total number of participants approached.
Conditions Studied
Interventions
- BEHAVIORAL Mobile Health Messaging application
- OTHER Standard of Care Treatment
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-05-02 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What NCT03738410 shows while recruiting
NCT03738410 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 33,179-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower).
The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 2 interventions - of which Mobile Health Messaging application is the first listed.
NCT03738410 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03738410 about?
NCT03738410 is a clinical study titled "An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS". The purpose of this study is: 1. To develop a new mobile health (mHealth) system that will send text messages to remind both pregnant and non-pregnant women with HIV to adhere to their treatment plan (like keeping appointments, fillings prescriptions, and taking their medication) and address indivi...
What is the current status of trial NCT03738410?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-05-02. Estimated completion is 2026-07-31.
What conditions does trial NCT03738410 study?
This clinical trial studies the following conditions: HIV/AIDS.
What interventions are being tested in trial NCT03738410?
The interventions under investigation include: Mobile Health Messaging application (BEHAVIORAL), Standard of Care Treatment (OTHER).
Who is sponsoring clinical trial NCT03738410?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03738410 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV/AIDS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03738410's enrollment target sits among peer trials
80 38th of 61 higher than 23 of 61 other HIV/AIDS trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV/AIDS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Mobile Gaming App to Improve Adherence to PrEP
RECRUITING · NA
-
LinkPositively+ A Mobile Health App Delivered Intervention to Improve HIV Care Outcomes Among Black Women Affected by Mental Health and Violence
RECRUITING · NA
-
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
RECRUITING · NA
-
MyPEEPS LITE Trial
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Improving the Organizational Social Context to Address Structural Racism and Discrimination
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI